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Abstract Melatonin, a metabolic product of the amino
acid tryptophan, induces a dose-dependent energy drop
correlated with a decrease in the oxidative phosphorylation
process in isolated rat liver mitochondria. This effect
involves a gradual decrease in the respiratory control index
and significant alterations in the state 4/state 3 transition of
membrane potential (DW). Melatonin, alone, does not
affect the insulating properties of the inner membrane but,
in the presence of supraphysiological Ca2?, induces a DW
drop and colloid-osmotic mitochondrial swelling. These
events are sensitive to cyclosporin A and the inhibitors of
Ca2? transport, indicative of the induction or amplification
of the mitochondrial permeability transition. This phe-
nomenon is triggered by oxidative stress induced by mel-
atonin and Ca2?, with the generation of hydrogen peroxide
and the consequent oxidation of sulfydryl groups, gluta-
thione and pyridine nucleotides. In addition, melatonin,
again in the presence of Ca2?, can also induce substantial
release of cytochrome C and AIF (apoptosis-inducing
factor), thus revealing its potential as a pro-apoptotic agent.
Keywords Melatonin  Mitochondria  Permeability
transition  Ca2?  Oxidative stress  Pro-apoptotic factors
Abbreviations
AdNT Adenine nucleotide translocator
AIF Apoptosis-inducing factor
BKA Bongkrekic acid
CsA Cyclosporin A
DTE Dithioerythritol
DE Electrical transmembrane potential
DlH? Transmembrane electrochemical gradient
DW Electric membrane potential
EGTA Ethylene glycol tetraacetic acid
MLT Melatonin
MPT Mitochondrial permeability transition
NEM N-Ethylmaleimide
RCI Respiratory control index
RHM Rat heart mitochondria
RLM Rat liver mitochondria
ROS Reactive oxygen species
RR Ruthenium red
tBOOH Tert-butylhydroperoxide
TPP? Tetraphenylphosphonium
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) (Fig. 1) is an
indolamine isolated for the first time by Aaron Lerner in
the 1950s from the bovine pineal gland (Lerner et al. 1958).
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Melatonin is widely found in nature, where it occurs in
vertebrates, invertebrates, plants, unicellular eukaryotes,
algae, and even bacteria. It is distributed ubiquitously
throughout an organism, due to its amphiphilic nature
which makes it permeable to all cellular compartments
(Slominski et al. 2008).
Melatonin is a hormone produced especially by the
pineal gland or epiphysis, where the enzyme tryptophan
hydroxylase converts the amino acid tryptophan to
5-hydroxytryptophan. By the intervention of 5-hydroxy-
tryptophan decarboxylase, this pathway leads to the
production of serotonin, which is a substrate for N-acetyl-
transferase. N-acetylserotonin is methylated to form
melatonin, the production of which is controlled by the
suprachiasmatic nucleus of the hypothalamus. In addition,
its biosynthesis and release are inhibited by light, stimulated
by darkness and also regulated by noradrenergic activity
(Gutie´rrez et al. 2006). In mammals, the concentrations of
circulating melatonin vary over a 24-h period, its levels in
blood generally being high during the night and low during
the day (Pandi-Perumal et al. 2008, and references therein).
Melatonin receptors are amply distributed throughout
the body, and their expression differs among various target
organs. Its membrane-bound receptors include melatonin
receptors types 1 and 2 (MT1 and MT2) (Slominski et al.
2008).
Previous studies on rats indicated that melatonin might
be a wonderful integrator which could make people younger
and healthier, and perhaps even improve their sexual per-
formance (Arendt 1996; Bergstrom and Hakanson 1998).
Melatonin also seems to regulate the internal body
clock in case of great changes in time zones (e.g., jet lag)
(Herxheimer 2006). Indeed, different studies show that the
circadian rhythm of many species of reptiles, birds and
mammals, including humans, may be synchronized by doses
of exogenous melatonin (Cassone 1990; Buscemi et al.
2006).
Melatonin has also been claimed to inhibit the growth of
cancer cells in vitro, although it can promote melanoma
growth in hamsters. On the strength of these preliminary
observations with opposite meanings, the possible clinical
uses of melatonin as adjuvant treatment in chemotherapy or
immunotherapy are too premature for results to be evalu-
ated properly (Arendt 1996, and references therein).
The effects of melatonin on mitochondria are difficult to
summarize, for several reasons: they were obtained under
differing experimental conditions, often with de-energized
organelles, and show ample variations according to the
organ, tissue and cell type examined (Srinivasan et al.
2008; Bu¨yu¨kavcı et al. 2006).
It has been reported very recently that melatonin inhibits
cardiolipin peroxidation in rat heart mitochondria (RHM)
and prevents the mitochondrial permeability transition
(MPT) and cytochrome C release (Petrosillo et al. 2009). It
has also been found that the indolamine induces mito-
chondrial-mediated apoptosis in human myeloid HL-60
cells (Bejarano et al. 2009) but reduces this process in
human leukocytes (Espino et al. 2010). The differential
actions exhibited by melatonin on mitochondria and
apoptosis in normal and cancer cells were also previously
reported in a review article (Sainz et al. 2003).
In addition, as regards the physiological and pathologi-
cal concentrations of melatonin, its levels in various body
fluids and cells are not necessarily in equilibrium with
those in the blood (Reiter and Tan 2002) and this hormone,
as also observed in other compounds like flavonoids and
polyphenols (De Marchi et al. 2009; Salvi et al. 2002;
Battaglia et al. 2008), can show alternative actions as a
reducing or oxidative agent, depending on the structural
features of the target molecules and their environment, the
incubation time and the concentrations used (Osseni et al.
2000).
Some studies on sub-mitochondrial particles deriving
from brain and liver tissues show that doses of melatonin
significantly increase the activity of respiratory chain
complexes I and IV at the nanomolar level. Although these
concentrations are similar to the physiological ones found
in plasma at night, their values are not indicative of the
amount of melatonin present in the cells, because high
physiological values of melatonin have been found in dif-
fering tissues (even two or three orders of magnitude more
than the circulating level) (Martı´n et al. 2002).
Other studies have shown the neuroprotective effect of
melatonin: it can reduce brain damage and improves the
general neurological state in rats affected by ischemia
(Andrabi et al. 2004), and it is reported to have some
antioxidant and immunostimulant effects at high concen-
trations, although pro-oxidant and immunosuppressant
effects have also been described (Arendt 1996; Srinivasan
et al. 2008; Bu¨yu¨kavcı et al. 2006, Zhang et al. 2011).
In conclusion, our aim is to establish some precise
results concerning the interactions between melatonin and
Fig. 1 Molecular structure of melatonin
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isolated liver mitochondria, using undamaged organelles
able to carry out their energy functions. This was done in
order to ascertain whether the observed opposite results are
due to tissue specificity, different incubation media, or
different actions of melatonin between isolated and in situ
mitochondria.
In this study, we analyse the effects of melatonin on
bioenergetic mitochondrial parameters, its role in oxidative
stress, and its possible function on the establishment of the
MPT.
Materials and methods
Materials
Mouse monoclonal antibody anti-cytochrome C was pur-
chased from Pharmingen, and rabbit polyclonal antibody
anti-apoptosis-inducing factor (AIF) from Millipore. All
other reagents were purchased from Sigma, except where
indicated, and were of the highest purity commercially
available.
Isolation of rat liver mitochondria
Rat liver mitochondria (RLM) were isolated by conven-
tional differential centrifugation (Schneider and Hogeboom
1950) in a standard medium containing 250 mM sucrose,
5 mM Hepes (pH 7.4) and 1 mM EGTA; EGTA was
omitted from the final washing solution. Protein content
was measured by the biuret method with bovine serum
albumin as standard (Gornall et al. 1949).
These studies were performed in accordance with the
guiding principles in the care and use of animals and were
approved by the Italian Ministry of Health.
Standard incubation procedure for RLM
RLM (1 mg prot/ml) were incubated in a water-jacketed
cell at 20C. The standard medium contained 200 mM
sucrose, 10 mM Hepes (pH 7.4), 5 mM succinate, 1.25 lM
rotenone, 1 mM phosphate. Variations and/or other addi-
tions are described with individual experiments presented.
Increasing phosphate concentration until 5 mM may
amplify melatonin effect.
Determination of mitochondrial functions
Membrane potential (DW) was measured in an open,
thermostatically controlled, stirred vessel, by monitoring
the distribution of the lipophilic cation tetraphenylphos-
phonium (TPP?) across the mitochondrial membrane with
a selective electrode, prepared according to published
procedures (Kamo et al. 1979). The obtained values were
corrected as reported by Jensen et al. (1986). DE value, the
electrode potential derived from TPP? distribution, was
added into Nernst equation in order to obtain the mito-
chondrial potential DW.
Oxygen uptake was measured by a Clark electrode
(Yellow Spring Instruments, OH) in a closed vessel
equipped with thermostatic control and magnetic stirrer.
ATP synthesis was measured by the enzymatic method of
Lemasters and Hackenbrock (1976).
Determination of mitochondrial swelling
Mitochondrial swelling was determined by measuring the
apparent absorbance change in mitochondrial suspensions
at 540 nm, on a Kontron Uvikon mod. 922 spectropho-
tometer equipped with thermostatic control.
Measurement of the redox level of RLM
Determination of protein sulfydryl groups and mitochon-
drial glutathione oxidation was carried out with mito-
chondrial suspensions from the various incubations used to
determine mitochondrial swelling. In brief, at the end of
incubation (12 min), the total suspension (1 mg/ml) was
placed in Eppendorf 4515c tubes and centrifuged for 1 min
at 12,000g; then the supernatant was discarded and the
pellet used for both measurements. A sulfydryl group
oxidation assay was performed after solubilization of the
pellet with 1 mg of solubilization medium (10 mM EDTA,
0,2 M Tris, 1% SDS, pH 8.3), with 5,50-dithio-bis-(2-
nitrobenzoic acid) at 412 nm in a Kontron Uvikon Model
922 spectrophotometer, according to Santos et al. (1998).
Glutathione oxidation was assessed by deproteinization
of the pellet with 3% metaphosphoric acid and subsequent
centrifugation to separate the supernatant on which oxi-
dised glutathione was determined by the method of Tietze
(1969). The redox state of endogenous pyridine nucleotides
was directly followed fluorometrically in a Shimadzu
spectrofluorophotometer RF-5000, with excitation at
354 nm and emission at 462 nm.
The production of H2O2 in RLM was measured fluoro-
metrically by the scopoletin method (Loschen et al. 1973)
in a Shimadzu spectrofluorophotometer RF-5000, with
excitation at 350 nm and emission at 460 nm.
Detection of cytochrome C and AIF release
Mitochondria (1 mg prot/ml) were incubated for the times
indicated in the specific experiments at 20C, in standard
medium, with the appropriate additions. The reaction
mixtures were then centrifuged at 13,000g for 10 min at
4C to obtain mitochondrial pellets. The supernatant
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fractions were concentrated five times with Pierce SDS-
PAGE sample Prep kit (Thermo Scientific). Aliquots of
10 ll of the concentrated supernatants were subjected to
SDS-PAGE with 15% (w/v) acrylamide gel for cytochrome
C detection and 10% acrylamide gel for AIF. After WB,
the nitrocellulose membranes were treated with the specific
antibodies anti-cytochrome C (Pharmingen) or anti-AIF
(Millipore), and analyzed by enhanced chemiluminescent
detection (ECL, GE Healthcare).
Results
A peculiar characteristic of energy-transducing mem-
branes, such as the inner mitochondrial membrane, is their
capacity to use the transmembrane electrochemical gradi-
ent (DlH
?), formed during the process of electron transport
along the respiratory chain, as a driving force for ATP
synthesis.
Experimentally, this process is usually detected by
determining the ‘‘respiratory control index’’ (RCI), which
is the respiratory rate ratio ‘‘state 3/state 4’’. In particular,
the active respiring state taking place during ATP synthesis
is called ‘‘state 3’’, and the slower rate, after all the ADP
has been phosphorylated to form ATP, is called ‘‘state 4’’.
On this basis, mitochondrial respiration is controlled by the
availability of ADP, phosphate, and an oxidizable substrate
which can create an electron flow along the respiratory
chain, with the consequent promotion of DlH
?.
The RCI indicates the effectiveness of the mitochondria
in promoting oxidative phosphorylation and thus the
tightness of the coupling between oxygen consumption and
ATP production. Typical RCI values range from 3 to 10,
varying with the substrate and the quality of the mito-
chondrial preparation. Obviously, high values indicate a
better biochemical function.
The reported results (Fig. 2) indicate that RLM, incu-
bated in standard medium with succinate as substrate, in
the conditions reported in ‘‘Materials and methods’’,
exhibit an RCI of 10. The presence of 10 lM melatonin
causes the RCI to fall to 2.8. Higher concentrations (20 and
40 lM) further reduce the index until complete uncoupling
(RCI = 1 with melatonin 80 lM) (Table in Fig. 2).
Uncoupled respiration by FCCP is not affected by 80 lM
melatonin because this compound, at the concentration
used, is able to cause a complete uncoupling effect (Fig. 2).
Mitochondrial inner membrane integrity and function
can be estimated by DW determination, a value which
indicates the membrane insulating capacity. DW is one of
two factors (the other being DpH) which constitute the
DlH
?. During ATP synthesis, a drop in DlH
? is experimen-
tally appreciable by a transient decrease in DW. This is
observable by adding ADP to the mitochondrial suspension
containing phosphate, which induces an immediate and
transitory decrease in DW from 180 to 160 mV, then
restored to the initial value (e.g. state 3/state 4 transition).
In the presence of melatonin, a reduction in the DW drop
occurs, with only partial or negligible transient DW resto-
ration, both dose-dependent (Fig. 3). The subsequent
results deal with the estimation of melatonin effects on
membrane function, in the presence or absence of Ca2?.
Ca2? allows the possible action of melatonin as an inducer
or amplifier of the MPT to be measured. As Fig. 4a shows,
melatonin alone, even at increasing concentrations up to
60 lM, does not cause any significant variations in DW
(about 180 mV), when compared with control without
Ca2?. The addition of 40 lM Ca2? (Fig. 4b) causes a rapid
and transitory decrease in DW, due to the entry of positive
charges into the matrix, which is immediately equilibrated
by the increase in oxygen consumption and H? ejection
(Lo¨tscher et al. 1980), with a partial restoration of DW with
a subsequent slight decrease (control). If melatonin is
present in the incubation medium, after the transitory
variation noted with the addition of Ca2?, DW undergoes a
collapse, the rapidity and extent of which is dose-depen-
dent (Fig. 4b). MPT inhibitors—cyclosporin A (CsA)
which blocks the pore opening, the antioxidant dithio-
erythritol (DTE), Mg2? which binds the adenine nucleotide
translocator (AdNT) and prevents its conformational
exchange, the alkylant N-ethylmaleimide (NEM) and the
reactive oxygen species (ROS) scavenger spermine—pre-
vent the DW collapse caused by the contemporaneous
presence of melatonin and Ca2?. Instead, unexpectedly,
bongkrekic acid (BKA), one of the most powerful inhibi-
tors of transition pore opening, is almost completely inef-
fective (Fig. 4c). These results may indicate MPT
induction, caused by the synergic action of melatonin and
Ca2?. However, in order to confirm this hypothesis, we
evaluated whether mitochondria, incubated as described
above, undergo colloid-osmotic swelling. The results
(Fig. 5a) show that mitochondria, suspended in standard
medium with 20 lM melatonin and 40 lM Ca2?, exhibit a
decrease in apparent absorbance of about 0.4 units if
compared with control with Ca2? (control). The use of
melatonin or Ca2? alone induces only a very low decrease
in absorbance and a slight drop in DW. In addition, by
substituting the sucrose medium with a KCl medium,
according to previous observations (Hansson et al. 2010) a
slight reduction of the swelling induced by melatonin has
been found (Online Resources 1). Moreover, experiments
evaluating melatonin effect on mitochondrial membrane
potential and swelling have been performed also with
glutamate/malate instead of succinate/rotenone without
finding substantial differences (Online Resources 2 and 3).
In the presence of EGTA (a calcium chelant) or ruthe-
nium red (RR) (an inhibitor of calcium transport), the
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decrease in absorbance is completely blocked (Fig. 5a).
The effects of the other typical MPT inhibitors on mito-
chondrial swelling are shown in Fig. 5b. They all exhibit a
preventive effect, except BKA—the same outcome shown
in DW detection.
The observation that the reductant DTE and the alkylant
NEM prevent DW collapse and mitochondrial swelling
suggests that these events are caused by mitochondrial
oxidative stress. The redox state of sulfydryl groups,
glutathione and pyridine nucleotides was studied in order
to assess this possibility. As Fig. 6a shows, the incubation
of mitochondria with Ca2? (control) or melatonin alone
produces a decrease in the reduced state of thiols (SH
groups) by 30 and 16%, respectively, while the simulta-
neous presence of the two agents produces a 48% decrease
in reduced state. This reduction is clearly due to the for-
mation of the same percentage of oxidised disulphides.
NEM completely blocks the thiol oxidation induced by
a b
c d e
Fig. 2 Dose-dependent effect
of melatonin on respiratory
control index (RCI). RLM were
incubated in standard medium
in conditions indicated in
‘‘Materials and methods’’.
200 lM ADP was added where
indicated. Melatonin (MLT)
was present in medium at
increasing concentrations, as
indicated. Insert table: RCI
values with ±SD of five
experiments are reported, flux
rates and P/O values. A typical
experiment is reported; five
other replicates gave almost
identical results
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both agents whereas, in the same condition, DTE causes
only partial prevention. This different effect is most
probably due to the fact that NEM can easily cross the
membrane, whereas DTE is less permeable. A close anal-
ogy with sulfydryl group oxidation is observed with glu-
tathione. Melatonin and Ca2? perform the same oxidant
action, both alone and together (Fig. 6b). In this case too,
NEM exerts full protection, whereas the effect of DTE is
only partial.
Figure 7 shows that mitochondria incubated in standard
medium, in the absence of Ca2?, do not show any variation
in the redox level of pyridine nucleotides over time. The
presence of Ca2? (control) or melatonin alone causes some
oxidation of the nucleotides, but both agents together
induce rapid and more intense oxidation. Also in this case,
CsA and NEM have a complete preventive effect on the
oxidant action of melatonin and Ca2?.
The results shown in Figs. 6 and 7, demonstrating that
melatonin plus Ca2? induces oxidative stress, led us to
examine whether this effect was related to the production
of ROS. The results (Fig. 8) show that melatonin, in the
presence of Ca2?, causes a large increase in H2O2, when
compared with control in the absence of Ca2?. It should
also be noted Ca2? alone produces a significant amount of
hydrogen peroxide, as previously reported in the literature
(Grijalba et al. 1999; Battaglia et al. 2010), whereas mel-
atonin alone does not cause any production of ROS. A very
recent paper reporting the induction of ROS production by
melatonin in isolated mitochondria from human mesangial
cells and mice kidney tissues is in agreement with our data
(Zhang et al. 2011).
As MPT induction is often linked to apoptosis, due to
the release of pro-apoptotic factors, the subsequent exper-
iment examined this possibility. As Fig. 9 shows, a con-
siderable loss of AIF and cytochrome C takes place when
RLM are incubated with melatonin and Ca2?. This is clear
from the intensity of lane 4, as revealed by Western blot-
ting of the supernatant fraction. Melatonin without Ca2?
has an almost negligible effect on cytochrome C release,
but AIF is released in greater quantities (lane 3), although
to a lesser extent than with Ca2? (compare with lane 4). In
any case, both amounts released in this condition (without
Ca2?) are similar to control (compare with lane 1). Ca2?
alone induces a considerable release of cytochrome C,
whereas that of AIF is similar to control (lane 2). In this
figure it is also shown that the mitochondrial fraction is
compared with the protein content that is released during
MPT induction (supernatant fraction).
This effect on cytochrome C is probably caused by
attenuation of electrostatic interactions, responsible for the
binding of this protein to the external surface of the inner
mitochondrial membrane and also to possible induction of
the permeability transition of the outer membrane. CsA
effectively prevents the release caused by melatonin plus
Ca2? (lane 5), demonstrating that this effect is closely
correlated with transition pore opening.
Discussion
As emphasised in the ‘‘Introduction’’, there are many data
about the biological effects of melatonin, often in opposi-
tion and sometimes not supported by well-designed
experimental approaches, especially in studies on mito-
chondrial function. In this regard, the main target of this
study was to ascertain some essential points regarding the
action of melatonin on the bioenergetic functions of
mitochondria, in order to clarify whether melatonin may be
considered toxic or beneficial to organelles.
The results shown in Figs. 2 and 3 clearly demonstrate
that melatonin causes a collapse in the mitochondria bio-
energetic in a dose-dependent fashion, as revealed by the
decreased RCI and alterations in the state 4/state 3 transi-
tion at DW level. These results cannot clarify whether this
damage is caused by specific lesions to membrane struc-
tures or direct interaction between melatonin and the ATP-
synthase system. However, the lack of any change in the
normal value of DW, which is 180 mV (Fig. 4a), observed
without ADP addition, and the alterations in the state
4/state 3 transition evaluated on DW during ATP synthesis,
suggest that melatonin acts at the level of ATP-synthase.
The observation that the respiration rate in state 4 is
gradually increased by enhanced melatonin concentration
(Fig. 2 and table therein), without changing DW (Fig. 4a),
also suggests stimulation of respiratory chain activity. The
lack in the effect by high melatonin concentration on
uncoupled respiration confirms that it does not inhibit the
respiratory chain. Another important observation, which
Fig. 3 Effect of melatonin on state4/state3 transition of DW. RLM
were incubated in standard medium, in presence of 2 lM TPP? for
DW measurement, in conditions indicated in ‘‘Materials and meth-
ods’’. 200 lM ADP was added where indicated. Melatonin (MLT)
was present at indicated concentrations. Four other replicates showed
similar results. DE electrode potential
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demonstrates the unequivocal action of melatonin on
mitochondrial membrane permeability, regards its effect in
the presence of Ca2?. In this condition, melatonin induces
dose-dependent DW collapse (Fig. 4b, c) and an increase in
mitochondrial swelling (Fig. 5a, b), demonstrating that it
behaves as a typical inducer or amplifier of the MPT.
This statement is further confirmed by inhibition by
CsA, a specific inhibitor of MPT, and by the physiological
MPT inhibitors, Mg2? and spermine (Figs. 4c, 5b).
The dependence of this phenomenon on Ca2? is dem-
onstrated by the complete inhibition of mitochondrial
swelling shown by EGTA and RR (Fig. 5a). Instead, the
slight inhibition of BKA, another typical inhibitor of MPT,
raises the debated problem regarding the identification of
the main protein involved in pore opening. As previously
reported, the proposal that the AdNT, which is inhibited by
BKA, holding up ATP/ADP exchange, is responsible for
pore opening, has been challenged with the proposal of
other protein(s), including the phosphate carrier (Leung
and Halestrap 2008; Leung et al. 2008). The inefficacy
exhibited by BKA, together with the inhibition of MPT by
NEM, which also inhibits the phosphate transporter,
a
b
c
Fig. 4 Effect of melatonin on
DW of RLM incubated in
absence (a) or presence (b) of
Ca2?. Effect of MPT inhibitors
on DW collapse induced by
melatonin plus Ca2? (c). RLM
were incubated as in Fig. 3 and
40 lM Ca2? was added to all
curves except where indicated.
a, b Melatonin (MLT) was
present at concentrations
reported on side of curves.
c Melatonin was present at
20 lM. When present: 6 lM
BKA, 1 lM CsA, 5 mM DTE,
1 mM Mg2?, 10 lM NEM,
100 lM spermine. Four
replicates gave comparable
results. DE electrode potential
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supports this suggestion. In any case, the protective effect
exerted by NEM and DTE on MPT is evidenced that the
alkylation or reduction of critical thiol groups on AdNT, or
phosphate carrier, prevents the opening of the transition
pore and suggests the oxidant effect of melatonin on
mitochondria. This proposal is strongly supported by oxi-
dative stress, albeit slight, induced by the compound alone,
as shown by the oxidation of thiols, glutathione and pyri-
dine nucleotides (Figs. 6, 7).
In the presence of Ca2? (necessary for MPT induction),
a synergetic effect is exerted on oxidative stress, which is
completely prevented—again by NEM, and partially by
DTE (Figs. 6, 7). The mechanism by which melatonin
induces oxidative stress cannot be deduced from the
experimental data reported here. As Fig. 8 shows, mela-
tonin and Ca2?, incubated together, induce the production
of a significant amount of H2O2. Ca
2? produces H2O2 by
interacting with membrane cardiolipin with the result of
membrane disorganization and consequent alteration of
ubiquinone mobility leading to ROS generation (Grijalba
et al. 1999). However, it should be noted that Ca2?, alone,
is able to produce the H2O2, whereas melatonin seems to be
ineffective. It should also be recalled that H2O2 can only be
detected outside the mitochondria and that the measured
amount depends on the location of its generation, which
may differ between melatonin and Ca2? and, consequently,
on the reaction rate with its targets and external diffusion
rate. In other words, it is possible that melatonin, alone, can
produce H2O2 but it can also very rapidly react or be
transformed into other ROS, in which case it can no longer
be detected.
It is also noteworthy that the effects of melatonin are
similar to those exhibited in RLM by another biogenic
amine, agmatine, which is oxidised in mitochondria by an
amine oxidase (Cardillo et al. 2009), with production of
ROS and opening of the transition pore (Agostinelli et al.
2009). Experiments are in progress in our laboratories to
ascertain whether the action of melatonin is related to
similar catabolism.
The oxidative stress induced by melatonin (Figs. 6, 7)
and the consequent MPT induction in liver, in the light of
a
b
Fig. 5 Induction of mitochondrial swelling in the presence of Ca2?.
Effects of Ca2? transport inhibitors (a) and MPT inhibitors (b). RLM
were incubated in standard medium in presence of 20 lM melatonin
(MLT) and 40 lM Ca2?. When present: 1 lM CsA, 6 lM BKA,
5 mM DTE, 1 mM EGTA, 10 lM NEM, 1 lM RR, 100 lM
spermine. Assays were performed at least four times with similar
results. Downward deflections indicate mitochondrial swelling
a
b
Fig. 6 Mitochondrial thiol (a) and glutathione (b) oxidation induced
by melatonin. All incubations were carried out as indicated in
‘‘Materials and methods’’ in presence of 40 lM Ca2?, except where
indicated (-Ca2?). When present: 20 lM melatonin (MLT), 5 mM
DTE, 10 lM NEM. Data are expressed as percentage of thiol or
glutathione reduction, and represent average ± mean SD from five
independent experiments
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the opposite results observed in RHM (Petrosillo et al.
2009), may be explained by considering that these authors
used pyruvate plus malate as energizing substrates and tert-
butylhydroperoxide (tBOOH) as MPT inducer. In these
conditions, tBOOH produces the hydroxyl and peroxyl
radicals responsible for the MPT induction and cytochrome
C release, whereas melatonin protects by scavenging both
radicals (Matuszak et al. 1997; Pieri et al. 1994). In our
experiments with RLM, the substrate was succinate, which
sends electrons to the respiratory chain through Complex II
(succinate dehydrogenase) and ubiquinone. This complex
contains heme b, which is not involved in electron trans-
port but which serves as an electron sink to prevent leakage
out of the respiratory chain (Yankovskaya et al. 2003).
The observed oxidative stress induced by melatonin
alone, most probably responsible for pore opening in
the presence of Ca2?, is explained by considering that the
indolamine favors the above leakage and hampers the
function of heme b. In these conditions, regular electron
flux from succinate toward ubiquinone would be inhibited
and the semiquinone radical would be stabilized. Subse-
quently, the reaction of the radical with molecular oxygen
would produce superoxide anion. One proposal is that this
ROS, which cannot be scavenged by melatonin (Chan and
Tang 1996), oxidises the critical sulfydryl groups respon-
sible for pore opening (McStay et al. 2002). It is also
assumed that H2O2 is generated in small amounts in the
absence of Ca2?, but it is not detectable as explained
above. Instead, in the presence of Ca2?, a large amount of
H2O2 is generated, caused by pore opening which induces
further oxidative stress (Fig. 8). This mechanism reported
here would explain the different effect exhibited by mel-
atonin in preventing MPT (Petrosillo et al. 2009) or in
inducing it (this paper). In the first case melatonin scav-
enges both the hydroxyl and peroxyl radicals generated by
tBOOH, without involving the electron flux triggered by
pyruvate/malate. In the later, melatonin favors the gener-
ation of superoxide anion, a ROS that is not scavenged by
melatonin itself (Chan and Tang 1996). In this case the
electron flux is triggered by succinate and directly affected
by the interaction with melatonin, which generates the
ROS.
It should be noted that, although melatonin and Ca2?,
alone, induce oxidative stress, they are not able to induce
the MPT (Fig. 5), which can only take place when both the
agents are incubated together. This is because pore opening
requires the interaction of Ca2? with its specific
site(s) located on AdNT or phosphate carrier (Leung and
Halestrap 2008; Leung et al. 2008). Concomitantly, two
specific thiols, located on the AdNT, have to be oxidised
(Mcstay et al. 2002). In fact, Ca2? alone can bind to the
specific site, but ROS, most probably produced by itself,
although giving rise to oxidative stress, are not able to react
Fig. 7 Oxidation of pyridine nucleotides induced by melatonin. RLM
were incubated in standard medium in presence of 40 lM Ca2?,
except where indicated (-Ca2?). When present: 20 lM melatonin
(MLT), 1 lM CsA, 10 lM NEM. Five additional assays exhibited
same trend in fluorescence change
Fig. 8 Mitochondrial hydrogen peroxide production by Ca2? and
melatonin. Incubation conditions and reagent concentrations as in
Fig. 7. Mean values from four experiments
Fig. 9 Release of AIF and cytocrome C (Cyt C) induced by
melatonin in presence of Ca2? and cyclosporine A. Results of
Western blotting of supernatant and mitochondrial fractions. Incuba-
tion conditions and reagent concentrations as in Fig. 7. Lane 1 control
(-Ca2?), lane 2 control, lane 3 melatonin (MLT) (-Ca2?), lane 4
melatonin (MLT), lane 5 melatonin (MLT) and CsA. Assays
performed four times with almost identical results
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with the specific thiol groups, perhaps because they are not
produced near them. Conversely, melatonin induces oxi-
dation of thiols but cannot induce the binding of Ca2?. In
both cases, the above necessary requirements for pore
opening are not satisfied.
Observations of the ability of melatonin to cause the
MPT through oxidative stress support the hypothesis that
this hormone is potentially a pro-apoptotic agent. Figure 9,
showing that mitochondria incubated with calcium and
melatonin suffer a loss of cytochrome C and AIF, not only
demonstrates this pro-apoptotic potential of melatonin, but
is also indicative of the potential activation of both cas-
pase-dependent and caspase-independent pathways.
These early results clearly demonstrate that, in the
specific experimental conditions used, RLM treated with
melatonin and calcium undergo oxidative stress, leading to
the induction of MPT and the release of pro-apoptotic
factors.
The observed opposite effects of melatonin in isolated
mitochondria match previous observations of mitochon-
drial-mediated apoptosis in normal and cancer cells, as
emphasized in a former review (Sainz et al. 2003). A very
recent paper reports that melatonin protects human leuco-
cytes against MPT induction and apoptosis. The authors
suggest the same mechanism proposed for RHM (see
above), i.e., that melatonin protects by scavenging hydro-
xyl and peroxyl radicals responsible for the oxidative stress
leading to apoptosis (Espino et al. 2010). Another recent
paper reports that, in human myeloid HL-60 cells, mela-
tonin induces caspase activation accompanied by mito-
chondrial depolarization, induction of MPT, release of
cytochrome C, and apoptosis (Bejarano et al. 2009). These
findings match our results in RLM, although the authors do
not report any effect regarding possible oxidative stress
induced by melatonin. They suggest the involvement of the
Bid/Bax signal, which cannot be considered in isolated
RLM. However, Wo¨lfler et al. (2001)reported that mela-
tonin induces the formation of ROS in human leukemic
Jurkat cells, leading to apoptosis. In this case, the mecha-
nism of ROS generation is controversial, but their
involvement and the lack of scavenging effect by melato-
nin are unequivocal. Both these studies confirm that mel-
atonin only scavenges some forms of radicals (e.g.,
hydroxyl and peroxyl) whereas for others (superoxide
anion and H2O2) it is ineffective. The indication that
apoptosis occurs in Jurkat cells also strongly supports the
mechanism proposed by us for MPT induction.
It is also reasonable to believe that these results, in a
pathophysiological context and in cellular systems, may
represent an important defence aspect for the organism,
initiated by the action of melatonin.
As emphasized above, our results are preliminary and
need to be completed and evaluated on more complex
biological systems than isolated mitochondria, in particular
hepatocytes and hepatoma cells, in order to ascertain the
potential of melatonin as a pro-apoptotic and anticancer
agent in these types of cells, as the results on isolated RLM
seem to indicate.
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